Sharon Savage
banner
telomeredoc.bsky.social
Sharon Savage
@telomeredoc.bsky.social
🧬 📊 🧫 🧪
Views expressed are mine and mine alone
February 15, 2025 at 12:45 PM
February 9, 2025 at 4:00 PM
Genome-first approach data GATA2, RUNX1, ETV6 defines population prevalence of pathogenic variants. Age at myeloid malignancy w/ DDX41 similar to age in general population but risk higher. #ASH24 #Leukemia
Dr McReynolds #NCI_ClinicalGenetics
December 8, 2024 at 7:00 PM
Who’s ready to run?! Fog is burning off. Beautiful day ahead
#ASH24 #5K #ASHFoundation
December 8, 2024 at 3:11 PM
The #CCCTAA at #ASH24. Look for important international collaborative studies on #telomere biology disorders in the near future. @teamtelomere.bsky.social is a key partner.
Reach out to join the Clinical Care Consortium of Telomere Associated Ailments 🧬 #teamscience
December 7, 2024 at 10:18 PM
More than 50 million screened, to date. Amazing program aimed at reducing the burden is #SCD in #India
#ASH24
December 7, 2024 at 9:05 PM
An inspiring talk by Dr Jain on her groundbreaking work on #SCD in India - defining the disease, practical approaches to therapy, and patient advocacy
#ASH24
#sicklecelldisease
December 7, 2024 at 9:01 PM
Saving the best (but I “may” be biased) for last in #ASH24 germline workshop - Dr. Maryam Rafati from #NCI_ClinicalGenetics presenting on heterozygous #DNA repair gene variants & #HCT outcomes. MUTYH carriers had poorer outcomes if received #TBI
Collab w/ #CIBMTR
December 7, 2024 at 1:27 AM